Five cases of paralytic strabismus as a rare feature of lyme disease

Clinical Infectious Diseases

Volumn 48, Issue 6, 2009, Pages 756-759

  Sauer, Arnaud ^a,c   Hansmann, Yves ^b   Jaulhac, Benoit ^c   Bourcier, Tristan ^a   Speeg Schatz, Claude ^b  

^a Departments of Ophthalmology   (France)

^b Department of Infectious Disease Pole Specialty Medecine Ophthalmology Hygiene ^*  (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BOTULINUM TOXIN; CEFTRIAXONE; CORTICOSTEROID; DOXYCYCLINE; PREDNISOLONE;

ABDUCENS NERVE PARALYSIS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD SAMPLING; BORRELIA BURGDORFERI; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; HUMAN TISSUE; LYME DISEASE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RARE DISEASE; STRABISMUS; TREATMENT DURATION; UVEITIS; WESTERN BLOTTING; CASE REPORT; ISOLATION AND PURIFICATION; MIDDLE AGED;

ADULT; BORRELIA BURGDORFERI GROUP; CHILD, PRESCHOOL; FEMALE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; STRABISMUS;

EID: 62449212501     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597041     Document Type: Article

References (15)

1. 16th Consensus conference on treatment of infectious diseases. Lyme disease (borreliosisj-diagnostic approach, therapy and prevention [in French]. Société de Pathologie Infectieuse de Langue Française. Rev Neurol (Paris) 2007;163:1273-9.
2. Stanek G, Gray J, Strle F, Wormser G. Lyme borreliosis. Lancet Infect Dis 2004;4:197-8; discussion 8-9.
3. Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med 2008; 14:205-12.
4. Yanagihara Y, Masuzawa T. Lyme disease (Lyme borreliosisj. FEMS Immunol Med Microbiol 1997;18:249-61.
5. Mikkila HO, Seppala IT, Viljanen MK, Peltomaa MP, Karma A. The expanding clinical spectrum of ocular Lyme borreliosis. Ophthalmology 2000; 107:581-7.
6. Lesser RL, Kornmehl EW, Pachner AR, et al. Neuro-ophthalmologic manifestations of Lyme disease. Ophthalmology 1990;97:699-706.
7. Bergloff I, Gasser R, Feigl B. Ophthalmic manifestations in Lyme borreliosis: a review. J Neuroophthalmol 1994;14:15-20.
8. Bodaghi B. Ocular manifestations of Lyme disease [in French|. Med Mai Infect 2007;37:518-22.
9. Hauser U, Krahl H, Peters H, Lingerie V, Wilske B. Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato. J Clin Microbiol 1998; 36:427-36.
10. Kaiser R, Lucking CH. Intrathecal synthesis of specific antibodies in neuroborreliosis: comparison of different ELISA techniques and calculation methods. J Neurol Sci 1993;118:64-72.
11. Robertson J, Guy E, Andrews N, et al. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 2000;38:2097-102.
12. Blanc F, laulhac B, Fleury M, et al. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 2007;69:953-8.
13. Huycke MM, D'Alessio DD, Marx JJ. Prevalence of antibodyto Borrelia burgdorferi by indirect fluorescent antibody assay, ELISA, and western immunoblot in healthy adults in Wisconsin and Arizona. J Infect Dis 1992;165:1133-7.
14. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005; 18:484-509.
15. Bratton RL, Whiteside JW, Hovan MJ, Engle RL, Edwards FD. Diagnosis and treatment of Lyme disease. Mayo Clin Proc 2008;83:566-71.